Paradoxical interpretations of noninferiority studies: violating the excluded middle

Author： DiNubile Mark J   Sklar Peter   Lupinacci Robert J   Eron Jr Joseph J  

Publisher： Future Medicine

ISSN： 1746-0794

Source： Future Virology, Vol.7, Iss.11, 2012-11, pp. : 1055-1063

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Choice of  Noninferiority Margin and Dependency of the Noninferiority Trials

By Tsong Yi   Zhang Joanne   Levenson Mark  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 2, 2007-03 ,pp. : 279-288

Taylor & Francis Ltd

Access to resources Recommend Favorite

A Cost-Effectiveness Analysis to Illustrate the Impact of Cost Definitions on Results, Interpretations and Comparability of Pharmacoeconomic Studies in the US

By Tunis Sandra L.  

PharmacoEconomics, Vol. 27, Iss. 9, 2009-09 ,pp. : 735-744

Adis International

Access to resources Recommend Favorite

Paradoxical Role of Cytochrome P450 3A in the Bioactivation and Clinical Effects of Levo- -Acetylmethadol: Importance of Clinical Investigations to Validate In Vitro Drug Metabolism Studies

By Kharasch Evan D.   Whittington Dale  

Clinical Pharmacokinetics, Vol. 44, Iss. 7, 2005-01 ,pp. : 731-751

Adis International

Access to resources Recommend Favorite

Bayesian Approach to Noninferiority Trials for Proportions

By Gamalo Mark A.  

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 5, 2011-09 ,pp. : 902-919

Taylor & Francis Ltd

Access to resources Recommend Favorite

Paradoxical and Bidirectional Drug Effects

By Smith Silas W.   Hauben Manfred   Aronson Jeffrey K.  

Drug Safety, Vol. 35, Iss. 3, 2012-03 ,pp. : 173-189

Adis International

Access to resources Recommend Favorite